Pharmaceutical Associates recalls
Pharmaceutical Associates has 3 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 5 Feb 2020. The most frequent reason is potency & assay.
Total recalls3since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Feb 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why pharmaceutical associates is recalled
By year
All pharmaceutical associates recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nystatin Oral Suspension, USP per mL Cherry/Peppermint Flavor recalledNystatin | Pharmaceutical Associates | Potency & Assay | Nationwide |
| Drug | CLASS III | Nystatin Oral Suspension, USP, For Institutional Use Only recalledNystatin | Pharmaceutical Associates | Potency & Assay | Nationwide |
| Drug | CLASS II | Cyproheptadine HCl Syrup (Cyproheptadine HCl Oral Solution, USP) 4mg recalled | Pharmaceutical Associates | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.